|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Nie, Xin; Zheng, Mingjun; Gao, Lingling; Hu, Yuexin; Zhuang, Yuan; Li, Xiao; Zhu, Liancheng; Liu, Juanjuan und Lin, Bei
(2022):
Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis.
In: International Immunopharmacology, Bd. 107, 108726
Gou, Rui; Zheng, Mingjun; Hu, Yuexin; Gao, Lingling; Wang, Shuang; Liu, Ouxuan; Li, Xiao; Zhu, Liancheng; Liu, Juanjuan und Lin, Bei
(2022):
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.
In: BMC Cancer, Bd. 22, Nr. 1, 690
Nie, Xin; Liu, Dawo; Zheng, Mingjun; Li, Xiao; Liu, Ouxuan; Guo, Qian; Zhu, Liancheng und Lin, Bei
(2022):
HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.
In: BMC Cancer, Bd. 22, Nr. 1, 1338
Gou, Rui; Hu, Yuexin; Liu, Ouxuan; Dong, Hui; Gao, Lingling; Wang, Shuang; Zheng, Mingjun; Li, Xiao und Lin, Bei
(1. Juli 2021):
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes.
In: Frontiers in Oncology, Bd. 11, 682461
[PDF, 5MB]
Hu, Yuexin; Zheng, Mingjun; Wang, Shuang; Gao, Lingling; Gou, Rui; Liu, Ouxuan; Dong, Hui; Li, Xiao und Lin, Bei
(2021):
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
In: Genomics, Bd. 113, Nr. 4: S. 2134-2144
Hu, Yuexin; Zheng, Mingjun; Zhang, Dandan; Gou, Rui; Liu, Ouxuan; Wang, Shuang und Lin, Bei
(2021):
Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.
In: Cancer Cell International, Bd. 21, Nr. 1, 516
Liu, Qing; Liu, Da-Wo; Zheng, Ming-Jun; Deng, Lu; Wang, Hui-Min; Jin, Shan; Liu, Juan-Juan; Hao, Ying-Ying; Zhu, Lian-Cheng und Lin, Bei
(2021):
Human epididymis protein 4 promotes P-glycoprotein-mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
In: Molecular Medicine Reports, Bd. 24, Nr. 1, 496
Nie, Xin; Gao, Lingling; Zheng, Mingjun; Wang, Caixia; Wang, Shuang; Li, Xiao; Qi, Yue; Zhu, Liancheng; Liu, Juanjuan und Lin, Bei
(2021):
Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells.
In: Journal of Cancer, Bd. 12, Nr. 19: S. 5772-5788
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Li, Siting; Nie, Xin; Li, Xiao und Lin, Bei
(2021):
Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.
In: Molecular Therapy-Oncolytics, Bd. 22: S. 294-306
Hu, Yuexin; Zheng, Mingjun; Wang, Caixia; Wang, Shuang; Gou, Rui; Liu, Ouxuan; Li, Xiao; Liu, Juanjuan und Lin, Bei
(2020):
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation.
In: American Journal of Translational Research, Bd. 12, Nr. 9: S. 4955-4976
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Nie, Xin; Li, Xiao; Liu, Juanjuan und Lin, Bei
(2020):
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
In: Biomedicine & Pharmacotherapy, Bd. 124, 109810
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Liu, Ouxuan; Nie, Xin; Li, Xiao; Liu, Qing; Hao, Yingying; Liu, Juanjuan und Lin, Bei
(2020):
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
In: Journal of Cellular and Molecular Medicine, Bd. 24, Nr. 5: S. 2819-2831
Hu, Yue-Xin; Zheng, Ming-Jun; Zhang, Wen-Chao; Li, Xiao; Gou, Rui; Nie, Xin; Liu, Qing; Hao, Ying-Ying; Liu, Juan-Juan und Lin, Bei
(2019):
Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.
In: Journal of Translational Medicine, Bd. 17, Nr. 1, 379